Alexandra P. Wolanskyj

Author

Also Known As

A P Wolanskyj, A. P. Wolanskyj-Spinner, A.P. Wolanskyj, A.P. Wolanskyj‐Spinner, ALEXANDRA P. WOLANSKYJ, Alexandra P Wolanskyj-Spinner, Alexandra P. Wolanskyj, Alexandra P. Wolanskyj-Spinner, Alexandra P. Wolanskyj‐Spinner, Alexandra Wolanskyj

106

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic in Arizona Mayo Clinic WinnMed Mayo Clinic in Florida Université de Montréal

About

Alexandra P. Wolanskyj is an author at Mayo Clinic in Arizona specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	2.3K
2	Health Sciences	5	5	172
3	Public Health	5	5	678
4	Education	1	1	13
5	Nursing	1	1	98

Alexandra P. Wolanskyj

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients Animesh Pardanani, Ross L. Levine, Terra L. Lasho, Blood	2006	1K
Essential Thrombocythemia Beyond the First Decade: Life Expectancy, Long-term Complication Rates, and Prognostic Factors Alexandra P. Wolanskyj, Susan M. Schwager, Rebecca F. McClure, Mayo Clinic Proceedings ThrombopoiesisThrombosisVenous ThrombosisCardiovascular DiseaseBlood Platelet	2006	325
Prognostic Factors and Outcomes of Adults With Hemophagocytic Lymphohistiocytosis Sameer A. Parikh, Prashant Kapoor, Louis Letendre, Mayo Clinic Proceedings Prognostic FactorsLymphoid NeoplasiaMedicineHematologyPathology	2014	315
<i>JAK2</i><sup>V617F</sup> mutation in essential thrombocythaemia: clinical associations and long‐term prognostic relevance Alexandra P. Wolanskyj, Terra L. Lasho, Susan M. Schwager, British Journal of Haematology Essential ThrombocythaemiaClinical AssociationsMixed-phenotype Acute LeukemiaImmunologyGenetic Epidemiology	2005	300
Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients Naseema Gangat, Alexandra P. Wolanskyj, Rebecca F. McClure, Leukemia ThrombopoiesisThrombosisHematological MalignancyVenous ThrombosisCardiovascular Disease	2006	202
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients Ayalew Tefferi, Emnet A Wassie, Paola Guglielmelli, American Journal of Hematology GeneticsGenetic EpidemiologyPathologyVersus Type 2Higher Platelet	2014	199
Clinical correlates of <i>JAK2</i>V617F allele burden in essential thrombocythemia Jaya Kittur, Ryan A. Knudson, Terra L. Lasho, Cancer	2007	154
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups Natasha Szuber, Mythri Mudireddy, Maura Nicolosi, Mayo Clinic Proceedings Hematological MalignancyMedicineOutcomes DataHematologyMyeloid Neoplasia	2019	151
COVID-19: Challenges and Opportunities for Educators and Generation Z Learners Ariela L. Marshall, Alexandra P. Wolanskyj Mayo Clinic Proceedings	2020	126
Dynamic phases of peroneal and tibial intraneural ganglia formation: a new dimension added to the unifying articular theory Robert J. Spinner, Kimberly K. Amrami, Alexandra P. Wolanskyj, Journal of neurosurgery	2007	112

Page 1